In April 2016, the FDA released a Drug Safety Communication warning about an increased risk of heart failure with saxagliptin, which stated, Type 2 diabetes medicines containing saxagliptin and alogliptin may increase the risk of heart failure, particularly in patients who already have heart or kidney disease
This is related to an imbalance in reactive oxygen species (ROS) homeostasis, which is mainly regulated by mitochondrial function, thereby suggesting a link between oxidative impairment in mitochondrial function in response to chronic stress and mood instability (Lushchak et al., 2023)
I am an overall very healthy person
However, despite the anti-diabetic and anti-obesity functions, of these dual and triple agonists, the long-term safety, cardiovascular, and renal benefits of these multi-target therapies need further validation
Taking the patients navel as the center, divide it outwards into 55 cm grid blocks
Glutathione and modulation of cell apoptosis